Update to the List of Compendia as Authoritative Sources for Use in the Determination of a “Medically-Accepted Indication” of Drugs and Biologicals Used Off-label in an Anti-Cancer Chemotherapeutic Regimen
This article is based on Change Request (CR) 9386 which announces that effective for
services on or after August 12, 2015, the Centers for Medicare & Medicaid Services (CMS)
is adding Wolters Kluwer Lexi-Drugs® to the list of authoritative compendia for use in the
determination of a medically-accepted indication of drugs and biologicals used off-label in
an anti-cancer chemotherapeutic regimen.
Final
Issued by: Centers for Medicare & Medicaid Services (CMS)
Issue Date: November 12, 2015
DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.